Table 1.
Baseline | Post-treatment | P-value 1 | |
---|---|---|---|
Gastrointestinal issues | |||
Constipation (%) | 17 | 17 | 1.00 |
Diarrhea (%) | 0 | 0 | 1.00 |
Water retention (%) | 2 | 2 | 1.00 |
Bad breath (%) | 14 | 29 | 0.15 |
Sleep disturbances | |||
Inability to fall asleep (%) | 0 | 0 | 1.00 |
Inability to stay asleep (%) | 7 | 2 | 0.50 |
Other adverse effects | |||
Dizziness (%) | 10 | 17 | 0.38 |
General weakness (%) | 14 | 10 | 0.69 |
Values reported as mean % occurrences at each time point (n = 59).
1P-value between baseline and post-treatment: McNemar test.